Parametric Portfolio Associates’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-125,235
| Closed | -$4.31M | – | 4071 |
|
|
2020
Q3 | $4.31M | Buy |
125,235
+52,924
| +73% | +$1.13M | ﹤0.01% | 2005 |
|
|
2020
Q2 | $1.21M | Buy |
72,311
+15,003
| +26% | +$255K | ﹤0.01% | 2813 |
|
|
2020
Q1 | $826K | Sell |
57,308
-34,924
| -38% | -$893K | ﹤0.01% | 2902 |
|
|
2019
Q4 | $3.09M | Buy |
92,232
+8,454
| +10% | +$236K | ﹤0.01% | 2399 |
|
|
2019
Q3 | $1.75M | Buy |
83,778
+31,040
| +59% | +$634K | ﹤0.01% | 2716 |
|
|
2019
Q2 | $1.1M | Buy |
52,738
+15,936
| +43% | +$328K | ﹤0.01% | 3005 |
|
|
2019
Q1 | $823K | Buy |
36,802
+8,251
| +29% | +$194K | ﹤0.01% | 3127 |
|
|
2018
Q4 | $683K | Buy |
28,551
+928
| +3% | +$24K | ﹤0.01% | 3168 |
|
|
2018
Q3 | $754K | Sell |
27,623
-5,277
| -16% | -$149K | ﹤0.01% | 3242 |
|
|
2018
Q2 | $885K | Buy |
32,900
+3,900
| +13% | +$119K | ﹤0.01% | 3113 |
|
|
2018
Q1 | $923K | Sell |
29,000
-4,476
| -13% | -$158K | ﹤0.01% | 3064 |
|
|
2017
Q4 | $1.27M | Buy |
33,476
+2,293
| +7% | +$74K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $773K | Buy |
31,183
+3,176
| +11% | +$68.5K | ﹤0.01% | 3178 |
|
|
2017
Q2 | $576K | Sell |
28,007
-15,713
| -36% | -$300K | ﹤0.01% | 3280 |
|
|
2017
Q1 | $950K | Sell |
43,720
-29,559
| -40% | -$606K | ﹤0.01% | 2888 |
|
|
2016
Q4 | $1.5M | Buy |
73,279
+24,733
| +51% | +$506K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $728K | Buy |
48,546
+276
| +0.6% | +$3.73K | ﹤0.01% | 2981 |
|
|
2016
Q2 | $522K | Buy |
48,270
+9,156
| +23% | +$124K | ﹤0.01% | 3166 |
|
|
2016
Q1 | $530K | Buy |
39,114
+22,837
| +140% | +$356K | ﹤0.01% | 3298 |
|
|
2015
Q4 | $300K | Buy |
+16,277
| New | +$301K | ﹤0.01% | 3565 |
|
Parametric Portfolio Associates's AIMT Position: Q4 2020 in Review
Parametric Portfolio Associates sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 125,235 shares — an estimated $4.31M sold.
Parametric Portfolio Associates first reported a position in AIMT in Q4 2015 and held it in 20 quarters. The position peaked at $4.31M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- Parametric Portfolio Associates reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 125,235 Aimmune Therapeutics shares in Q4 2020, an estimated $4.31M.
- Parametric Portfolio Associates first reported a position in Aimmune Therapeutics in Q4 2015 and held it in 20 quarters.
- Parametric Portfolio Associates's Aimmune Therapeutics position peaked at $4.31M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.